Antineoplastic drug used to treat multiple myeloma and certain other malignancies. Adverse effects include bone marrow depression, nausea, and vomiting.
A drug used to treat various types of cancer, including malignant melanoma, tumors of the breast and ovaries, and Hodgkin’s disease. It is administered by mouth or injection. Side-effects include digestive upsets, mouth ulcers, and temporary hair loss.
One of the alkylating agents, melphalan is used to treat certain forms of malignant disease including breast tumours, melanoma and Hodgkin’s lymphoma. It can be given orally or by injection.
This anti-cancer medication is employed for the treatment of multiple myeloma, along with specific forms of breast and ovarian cancer. Potential negative effects encompass nausea, vomiting, a sore throat, diminished appetite, decreased counts of red and other blood cells, unusual bleeding, and heightened vulnerability to infections.